4P Pharma team will be attending the upcoming BIO-Europe Spring 2016 on april 4 to 6 in Stokholm.
We are looking forward to meet potential partners there to discuss licensing-out opportunities of our abuse deterrent technologies 4P-003
Your good resolution for 2016:
Give your ideas a chance to become a reality with 4P Pharma!
Montpellier, December 1st 2015
In the context of an innovative medical drug development project for the treatment of cancers, called “Imiqualines”, the oncology-pharmaco-chemical and pharmaco-toxicological team of IBMM, SATT AxLR and 4P Pharma have concluded a co-development maturation agreement with a licensing option.
EN: Press release 4P Pharma-SATT AxLR 011215
FR: Communiqué de presse 4P Pharma-SATT AxLR 011215 Press release 4P Pharma-SATT AxLR 011215
4P Pharma
Revital Rattenbach
1 rue du Professeur Calmette, 59000 Lille
Tel: +33 (0)9 50 72 97 68
Université de Montpellier
Anne Delestre
CC 07-003 Place Eugène Bataillon, 34095 Montpellier cedex 5
Tel: +33 (0)4 34 43 31 93
CNRS
Aurélie Lieuvin
1919 route de Mende, 34293 Montpellier cedex 5
Tel: +33 (0)4 67 61 35 10
AxLR SATT
Franck-Léopold Erstein
1000, Avenue Agropolis, 34394 Montpellier cedex 5
Tel: +33 (0)6 07 28 21 43
We will be attending BioFIT 2015 in Strasbourg, France, on next December 1st and 2nd.
Come and meet us there to talk about innovation and learn more about our innovative model to accelerate preclinical drug development!
4P Pharma was featured in an article in Eco121, the North region economic magazine. Lille and the North region , is a very dynamic area for biotech, and we are pleased to benefit from the collaboration of Lille Pasteur Institute and Eurasanté.
Find the article written by O. Ducuing, here: http://www.eco121.fr/categorie/theme/entreprendre/
4P Pharma team wish you a wonderful holiday season and a happy 2015! May this new year be a source of accomplishment and joy for you and your loved ones.
